Does XYLOMETAZOLINE Cause Hypercholesterolaemia? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hypercholesterolaemia have been filed in association with XYLOMETAZOLINE (Metarivin Soln. 0.1%). This represents 2.8% of all adverse event reports for XYLOMETAZOLINE.
15
Reports of Hypercholesterolaemia with XYLOMETAZOLINE
2.8%
of all XYLOMETAZOLINE reports
15
Deaths
14
Hospitalizations
How Dangerous Is Hypercholesterolaemia From XYLOMETAZOLINE?
Of the 15 reports, 15 (100.0%) resulted in death, 14 (93.3%) required hospitalization, and 14 (93.3%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XYLOMETAZOLINE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does XYLOMETAZOLINE Cause?
Off label use (161)
Abdominal distension (155)
Nausea (155)
Hyponatraemia (154)
Stress (152)
Multiple organ dysfunction syndrome (151)
Abdominal pain (149)
General physical health deterioration (148)
Appendicitis (147)
Vomiting (147)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which XYLOMETAZOLINE Alternatives Have Lower Hypercholesterolaemia Risk?
XYLOMETAZOLINE vs XYREM
XYLOMETAZOLINE vs XYREM , /ML
XYLOMETAZOLINE vs YASMIN
XYLOMETAZOLINE vs YAZ
XYLOMETAZOLINE vs YTTRIUM Y-90